Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Southern California
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Thomas Jefferson University
City of Hope Medical Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
Thomas Jefferson University
Mayo Clinic
Mayo Clinic
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
OHSU Knight Cancer Institute
Virginia Commonwealth University